Despite MF Global, firms face weaker OTC safeguards

Segregated thinking

Scott O'Malia

The introduction of central clearing for over-the-counter derivatives has been sold as a way of making the market safer. But this claim is now being questioned by some buy-side firms, which say their collateral is better-protected today than it will be under segregation rules endorsed by the Commodity Futures Trading Commission (CFTC) in January. It is not clear, however, that they will be able to get the protection they want – even if they are willing to pay for it.

The CFTC rules are a

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: